Give Now

Gratitude inspires
hope and healing


We invite you to stay apprised of the latest developments at The Foundation for Barnes-Jewish Hospital by signing up for our newsletter. 

Illumination Gala Special Preview

Join us virtually on June 5 for our annual Illumination Gala to learn more about how the Cancer Frontier Fund is supporting breakthrough research at Siteman Cancer Center.

Read More

Effects of MS disease-modifying therapies on responses to vaccinations: A review

Development of long-term immunologic memory relies upon humoral and cellular immune responses.
Vaccinations aim to stimulate these responses against pathogens. Several studies have evaluated the
impact of multiple sclerosis disease-modifying therapies on immune response to vaccines. Findings from these
studies have important implications for people with multiple sclerosis who require vaccination and are using
disease-modifying therapies.

Read More

Can CSF biomarkers predict future MS disease activity and severity?

Multiple sclerosis (MS) is a heterogeneous disease. With several disease modifying treatments of different
mechanisms of action in use now and in development, it is important to identify reliable biomarkers
to identify those higher risk MS patients in whom stronger but riskier treatments might be used, as well as
to identify those for whom safer treatments of lower efficacy would be sufficient.

Read More